Maybe if they'd pressed the accelerator year ago, it would have been a better story for the company and SHs.
Many bios today reported a range of results and licence deals. New kids on the block with better prospects in near term, IMO.
DXB....check that licence deal out
NEU...phase 2 results
EMV....algorithms for their mobile medical device
If you want to see what a modern day marketing plan looks like check BOT out.
Ann: Positive final DEP irinotecan Phase 2 clinical trial results, page-19
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
